ESR1 and breast cancer: In the work of Purdie and others, the group of PR-negative patients, even the subgroups that otherwise would have a good prognosis- i.e. ER-positive and without lymph node infiltration, had significantly shortened the 5-year breast cancer specific survival, with or without application of chemotherapy87.